p53 mutations have no additional prognostic value over stage in bladder cancer
JAM Vet, Pierre‐Paul Bringuier, Pino J. Poddighe et al. · British Journal of Cancer · 1994
Cited by 50 works. doi:10.1038/bjc.1994.334 Open-access PDF
Authors
References
- A simple salting out procedure for extracting DNA from human nucleated cells
- A genetic model for colorectal tumorigenesis
- Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction
- Chromosome 17 Deletions and p53 Gene Mutations in Colorectal Carcinomas
- Participation of p53 protein in the cellular response to DNA damage.
- Allelotype of Colorectal Carcinomas
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
- Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53
- Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles
- Identification of p53 Gene Mutations in Bladder Cancers and Urine Samples